330 related articles for article (PubMed ID: 24121268)
1. The degradation of p53 and its major E3 ligase Mdm2 is differentially dependent on the proteasomal ubiquitin receptor S5a.
Sparks A; Dayal S; Das J; Robertson P; Menendez S; Saville MK
Oncogene; 2014 Sep; 33(38):4685-96. PubMed ID: 24121268
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin receptors play redundant roles in the proteasomal degradation of the p53 repressor MDM2.
Sparks A; Kelly CJ; Saville MK
FEBS Lett; 2022 Nov; 596(21):2746-2767. PubMed ID: 35735670
[TBL] [Abstract][Full Text] [Related]
3. Oligomerization conditions Mdm2-mediated efficient p53 polyubiquitylation but not its proteasomal degradation.
Hjerpe R; Aillet F; Lopitz-Otsoa F; Lang V; Torres-Ramos M; Farrás R; Hay RT; Rodríguez MS
Int J Biochem Cell Biol; 2010 May; 42(5):725-35. PubMed ID: 20080206
[TBL] [Abstract][Full Text] [Related]
4. HAUSP-nucleolin interaction is regulated by p53-Mdm2 complex in response to DNA damage response.
Lim KH; Park JJ; Gu BH; Kim JO; Park SG; Baek KH
Sci Rep; 2015 Aug; 5():12793. PubMed ID: 26238070
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin- and MDM2 E3 ligase-independent proteasomal turnover of nucleostemin in response to GTP depletion.
Lo D; Dai MS; Sun XX; Zeng SX; Lu H
J Biol Chem; 2012 Mar; 287(13):10013-10020. PubMed ID: 22318725
[TBL] [Abstract][Full Text] [Related]
6. HLA-B-associated transcript 3 (Bat3) stabilizes and activates p53 in a HAUSP-dependent manner.
Zhang R; Cui D; Xue T; Lang Y; Zhang Y; Li L; Sun H; Kuang Y; Li G; Tang J
J Mol Cell Biol; 2020 Feb; 12(2):99-112. PubMed ID: 31647545
[TBL] [Abstract][Full Text] [Related]
7. A post-ubiquitination role for MDM2 and hHR23A in the p53 degradation pathway.
Brignone C; Bradley KE; Kisselev AF; Grossman SR
Oncogene; 2004 May; 23(23):4121-9. PubMed ID: 15064742
[TBL] [Abstract][Full Text] [Related]
8. Suppression of the deubiquitinating enzyme USP5 causes the accumulation of unanchored polyubiquitin and the activation of p53.
Dayal S; Sparks A; Jacob J; Allende-Vega N; Lane DP; Saville MK
J Biol Chem; 2009 Feb; 284(8):5030-41. PubMed ID: 19098288
[TBL] [Abstract][Full Text] [Related]
9. p53 Ubiquitination and proteasomal degradation.
Love IM; Shi D; Grossman SR
Methods Mol Biol; 2013; 962():63-73. PubMed ID: 23150437
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the MDM2-p53 pathway by ribosomal protein L11 involves a post-ubiquitination mechanism.
Dai MS; Shi D; Jin Y; Sun XX; Zhang Y; Grossman SR; Lu H
J Biol Chem; 2006 Aug; 281(34):24304-13. PubMed ID: 16803902
[TBL] [Abstract][Full Text] [Related]
11. Differential interaction of the E3 ligase parkin with the proteasomal subunit S5a and the endocytic protein Eps15.
Safadi SS; Shaw GS
J Biol Chem; 2010 Jan; 285(2):1424-34. PubMed ID: 19875440
[TBL] [Abstract][Full Text] [Related]
12. The ubiquitin-interacting motifs of S5a as a unique upstream inhibitor of the 26S proteasome.
Elangovan M; Shin DY; Yoo YJ
Biochem Biophys Res Commun; 2009 Oct; 388(4):723-6. PubMed ID: 19695230
[TBL] [Abstract][Full Text] [Related]
13. The ubiquitin-interacting motif protein, S5a, is ubiquitinated by all types of ubiquitin ligases by a mechanism different from typical substrate recognition.
Uchiki T; Kim HT; Zhai B; Gygi SP; Johnston JA; O'Bryan JP; Goldberg AL
J Biol Chem; 2009 May; 284(19):12622-32. PubMed ID: 19240029
[TBL] [Abstract][Full Text] [Related]
14. FKBP25, a novel regulator of the p53 pathway, induces the degradation of MDM2 and activation of p53.
Ochocka AM; Kampanis P; Nicol S; Allende-Vega N; Cox M; Marcar L; Milne D; Fuller-Pace F; Meek D
FEBS Lett; 2009 Feb; 583(4):621-6. PubMed ID: 19166840
[TBL] [Abstract][Full Text] [Related]
15. ATM activates p53 by regulating MDM2 oligomerization and E3 processivity.
Cheng Q; Chen L; Li Z; Lane WS; Chen J
EMBO J; 2009 Dec; 28(24):3857-67. PubMed ID: 19816404
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the Mdm2-p53 pathway by the ubiquitin E3 ligase MARCH7.
Zhao K; Yang Y; Zhang G; Wang C; Wang D; Wu M; Mei Y
EMBO Rep; 2018 Feb; 19(2):305-319. PubMed ID: 29295817
[TBL] [Abstract][Full Text] [Related]
17. The p53-Mdm2 module and the ubiquitin system.
Michael D; Oren M
Semin Cancer Biol; 2003 Feb; 13(1):49-58. PubMed ID: 12507556
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 Nef promotes ubiquitination and proteasomal degradation of p53 tumor suppressor protein by using E6AP.
Ali A; Farooqui SR; Rai J; Singh J; Kumar V; Mishra R; Banerjea AC
Biochem Biophys Res Commun; 2020 Sep; 529(4):1038-1044. PubMed ID: 32819562
[TBL] [Abstract][Full Text] [Related]
19. RNF12 promotes p53-dependent cell growth suppression and apoptosis by targeting MDM2 for destruction.
Gao K; Wang C; Jin X; Xiao J; Zhang E; Yang X; Wang D; Huang H; Yu L; Zhang P
Cancer Lett; 2016 May; 375(1):133-141. PubMed ID: 26926424
[TBL] [Abstract][Full Text] [Related]
20. VWA domain of S5a restricts the ability to bind ubiquitin and Ubl to the 26S proteasome.
Piterman R; Braunstein I; Isakov E; Ziv T; Navon A; Cohen S; Stanhill A
Mol Biol Cell; 2014 Dec; 25(25):3988-98. PubMed ID: 25318673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
